ConductScience.org, home

Paper40670830

Exploring the role of inflammatory regulatory effects of probiotics as adjuvants in cancer development management with considering possible challenges: a comprehensive review.

Mahooti M and 7 others. Inflammopharmacology, 2025. Cited by 4 papers, by iCite.

Cite this record

ConductScience Library. Exploring the role of inflammatory regulatory effects of probiotics as adjuvants in cancer development management with considering possible challenges: a comprehensive review. Papers, record 40670830. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40670830

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Exploring the role of inflammatory regulatory effects of probiotics as adjuvants in cancer development management with considering possible challenges: a comprehensive review.
PubMed
Journal
Inflammopharmacology
PubMed
Year
2025
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
4
iCite
Revised in PubMed
2026-11-03
PubMed

Authors8

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Mahooti MMehran
2Safaei FFatemeh
3Firuzpour FFaezeh
4Abdolalipour EElahe
5Zare DDavood
6Sanami SSamira
7Safavi MMaliheh
8Mirdamadi SSaeedhttps://orcid.org/0000-0002-8356-771X

Source PubMed

Download CSV of authors

Topics8

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
ProbioticsMajor topic
NeoplasmsMajor topic
InflammationMajor topic
Adjuvants, ImmunologicMajor topic
Humans
Animals
Gastrointestinal Microbiome
Cytokines

Source PubMed

Download CSV of topics

References121

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
135115705Intestinal Akkermansia muciniphila predicts clinical response to PD-1 blockade in patients with advanced non-small-cell lung cancer.Nat Med2022https://conductscience.org/library/papers/35115705PubMed
233236974Probiotic Lactobacilli Enhance Immunogenicity of an Inactivated H9N2 Influenza Virus Vaccine in Chickens.Viral Immunol2021https://conductscience.org/library/papers/33236974PubMed
339435279The role of short-chain fatty acid metabolism in the pathogenesis, diagnosis and treatment of cancer.Front Oncol2024https://conductscience.org/library/papers/39435279PubMed
426749362Lactobacillus casei BL23 regulates Treg and Th17 T-cell populations and reduces DMH-associated colorectal cancer.J Gastroenterol2016https://conductscience.org/library/papers/26749362PubMed
527411589Caloric Restriction Mimetics Enhance Anticancer Immunosurveillance.Cancer Cell2016https://conductscience.org/library/papers/27411589PubMed
630523317The microbiome influence.Nat Med2018https://conductscience.org/library/papers/30523317PubMed
730530851Microbiota and cancer immunotherapy: in search of microbial signals.Gut2019https://conductscience.org/library/papers/30530851PubMed
830521105A randomized, double-blind, placebo-controlled trial of probiotics to reduce the severity of oral mucositis induced by chemoradiotherapy for patients with nasopharyngeal carcinoma.Cancer2019https://conductscience.org/library/papers/30521105PubMed
934052844Adjuvant treatment and molecular mechanism of probiotic compounds in patients with gastric cancer after gastrectomy.Food Funct2021https://conductscience.org/library/papers/34052844PubMed
1033764387Chronic Immune-Related Adverse Events Following Adjuvant Anti-PD-1 Therapy for High-risk Resected Melanoma.JAMA Oncol2021https://conductscience.org/library/papers/33764387PubMed
1137637950Remarkable impacts of probiotics supplementation in enhancing of the antioxidant status: results of an umbrella meta-analysis.Front Nutr2023https://conductscience.org/library/papers/37637950PubMed
1229232932Adjuvant Probiotics and the Intestinal Microbiome: Enhancing Vaccines and Immunotherapy Outcomes.Vaccines (Basel)2017https://conductscience.org/library/papers/29232932PubMed
1339475254Effect of combined probiotics and doxycycline therapy on the gut-skin axis in rosacea.mSystems2024https://conductscience.org/library/papers/39475254PubMed
1434926547Probiotics for the Treatment of Docetaxel-Related Weight Gain of Breast Cancer Patients-A Single-Center, Randomized, Double-Blind, and Placebo-Controlled Trial.Front Nutr2021https://conductscience.org/library/papers/34926547PubMed
1536307808Antioxidants in brain tumors: current therapeutic significance and future prospects.Mol Cancer2022https://conductscience.org/library/papers/36307808PubMed
1638944216Application of probiotics in cervical cancer infections to enhance the immune response.Microb Pathog2024https://conductscience.org/library/papers/38944216PubMed
1724487531H(2)O(2) production in species of the Lactobacillus acidophilus group: a central role for a novel NADH-dependent flavin reductase.Appl Environ Microbiol2014https://conductscience.org/library/papers/24487531PubMed
1829636538The gut microbiota influences anticancer immunosurveillance and general health.Nat Rev Clin Oncol2018https://conductscience.org/library/papers/29636538PubMed
1926311717Fusobacterium nucleatum in colorectal carcinoma tissue and patient prognosis.Gut2016https://conductscience.org/library/papers/26311717PubMed
2024976724Emerging roles of lactic acid bacteria in protection against colorectal cancer.World J Gastroenterol2014https://conductscience.org/library/papers/24976724PubMed

See all 121 referencesDownload CSV of references

Cited by3

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 4 citations.

PMIDTitleJournalYearIn PapersSource
42201634Efficacy of Probiotics and Postbiotics in Treating Dengue Fever - A Potential Strategy to Reduce Antibody-dependent Enhancement.Probiotics Antimicrob Proteins2026https://conductscience.org/library/papers/42201634PubMed
41149079Application and Challenges of Using Probiotic Lactobacillus and Bifidobacterium to Enhance Overall Health and Manage Diseases.Diseases2025https://conductscience.org/library/papers/41149079PubMed
41134485The Potential Anticancer Mechanisms of Probiotics: A Comprehensive Review.Probiotics Antimicrob Proteins2026https://conductscience.org/library/papers/41134485PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/40670830

GET https://conductscience.org/api/papers/v1/40670830/references?page=2